BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
51.30
0.12 (0.23%)
At close: Aug 15, 2025, 3:59 PM
51.00
-0.58%
After-hours: Aug 15, 2025, 07:58 PM EDT
BridgeBio Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -782.82M | -672.52M | -540.32M | -443.25M | -458.49M | -545.74M | -653.25M | -623.49M | -584.2M | -426.05M | -484.65M | -496.36M | -517.19M | -616.7M | -586.45M | -569.2M | -538.35M | -572.49M |
Depreciation & Amortization | 5.51M | 5.76M | 6.08M | 6.29M | 6.39M | 6.46M | 6.49M | 6.57M | 6.58M | 6.52M | 6.77M | 6.64M | 5.26M | 6.36M | 5.84M | 7.41M | 6.13M | 4.93M |
Stock-Based Compensation | 120.41M | 104.63M | 95.8M | 102.7M | 98.14M | 103.86M | 108.71M | 93.47M | 88.23M | 89.34M | 91.56M | 89.54M | 88.22M | 90.05M | 99.5M | 91.88M | 93.53M | 81.81M |
Other Working Capital | -2.32M | -971K | 33.5M | 28.36M | 27.7M | 44.75M | 2.28M | -3.15M | -12M | 8.69M | 28.43M | 37.19M | 73.46M | 1.72M | -7.23M | -20.16M | -43.76M | 15.25M |
Other Non-Cash Items | -29.13M | -195.53M | 145.59M | 125.19M | 171.15M | 298.96M | 23.49M | 28.4M | 18.21M | -79.34M | -61.25M | -71.52M | -57.64M | 36.92M | 18.5M | 28.15M | 31.48M | 36.37M |
Deferred Income Tax | n/a | n/a | n/a | -22.3M | -16.68M | -18.22M | -18.22M | 4.08M | -1.55M | n/a | n/a | -25.38M | -25.38M | -25.38M | -30.93M | -8.54M | -8.54M | -8.54M |
Change in Working Capital | 30.23M | 257.24M | 32.04M | 41.08M | 44.53M | -188.34M | 5.06M | -5.17M | -13.36M | 6.35M | 28.08M | 36.93M | 60.18M | 949K | -4.4M | -10M | -55.69M | -8.17M |
Operating Cash Flow | -655.81M | -500.42M | -520.73M | -450.22M | -414.88M | -602.93M | -527.72M | -496.14M | -486.08M | -403.18M | -419.49M | -460.15M | -446.54M | -507.8M | -497.93M | -460.3M | -470.42M | -466.56M |
Capital Expenditures | -10.06M | -7.42M | -8.91M | -6.11M | -4.8M | -2.79M | -1.31M | -1.67M | -2M | -5.47M | -6.32M | -8.06M | -48.76M | -47.14M | -48.25M | -47.86M | -6.94M | -5M |
Cash Acquisitions | n/a | -98K | -98K | -467K | -38.58M | -43.03M | -43.53M | -61.93M | -171.43M | -56.88M | -46.38M | 26.62M | 209.23M | 14.46M | 4.46M | -211.66M | -246.66M | -161.89M |
Purchase of Investments | -7.91M | -49.42M | -114.08M | -143.31M | -160.09M | -154.46M | -137.26M | -140.15M | -153.77M | -176.65M | -193.06M | -204.78M | -243.88M | -327.87M | -643.27M | -617.49M | -648.99M | -667.14M |
Sales Maturities Of Investments | 40M | 95M | 158.23M | 187.82M | 202.72M | 196.05M | 193.11M | 214.39M | 337.51M | 399.44M | 532.52M | 549.82M | 541.73M | 571.21M | 477.04M | 512.08M | 398.65M | 298.93M |
Other Investing Acitivies | -10.92M | -8.81M | 18.46M | 22.02M | 61.77M | 68.71M | 42.53M | 60.92M | 170.43M | 275.88M | 286.38M | 213.38M | 30.77M | -65.58M | -355.67M | -139.54M | -149.04M | -331.35M |
Investing Cash Flow | 20.39M | 36.43M | 60.78M | 63.95M | 63.41M | 64.49M | 54.03M | 72.06M | 181.24M | 326.82M | 453.15M | 456.98M | 369.09M | 219.85M | -200.83M | -139.61M | -243.63M | -373.07M |
Debt Repayment | 916M | 612.27M | 472.85M | -27.15M | -27.15M | -23.42M | n/a | n/a | n/a | -20.49M | -20.49M | 304.8M | 304.8M | 332.18M | 1.08B | 754.39M | 754.39M | 747.5M |
Common Stock Repurchased | -54.89M | -54.64M | -7.53M | -8.68M | -9.84M | -9.3M | -6.88M | -4.81M | -2.8M | -1.96M | -1.56M | -3.33M | -146.61M | -153.84M | -204.75M | -202.96M | -59.32M | -51.73M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -110.76M | -110.76M | -110.76M | -110.76M | n/a | n/a | n/a |
Other Financial Acitivies | 41.87M | 38.07M | -34.51M | -11.81M | -10.55M | -10.81M | 9.18M | 13.17M | 11.77M | 11.86M | 4.06M | 4.4M | 10.78M | 10.03M | -138.49M | -135.83M | -141.23M | -139.84M |
Financial Cash Flow | 837.01M | 529.24M | 748.46M | 270M | 576.34M | 580.83M | 451.54M | 462.44M | 156.84M | 137.28M | -13.13M | 305.87M | 168.97M | 188.37M | 736.45M | 415.6M | 553.83M | 555.93M |
Net Cash Flow | 201.59M | 65.25M | 288.51M | -116.26M | 224.87M | 42.39M | -22.15M | 38.35M | -148M | 60.92M | 20.52M | 302.71M | 91.52M | -99.58M | 37.69M | -184.31M | -160.22M | -283.7M |
Free Cash Flow | -665.87M | -507.84M | -529.63M | -456.32M | -419.68M | -605.72M | -529.03M | -497.82M | -488.08M | -408.65M | -425.81M | -468.2M | -495.3M | -554.95M | -546.18M | -508.16M | -477.37M | -471.56M |